Dr. Shulian Wang 王淑莲
Chief Physician
Department of Radiation Oncology, Cancer Hospital, Chinese Academy of Medical Sciences (National Cancer Center), Beijing
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Radiation therapy for breast cancer, gastrointestinal tumors, urinary tract tumors, lymphoma, and soft tissue sarcoma.
Dr. Wang is a Chief Physician with extensive clinical experience and in-depth research in radiation therapy for breast cancer, gastrointestinal tumors, urinary tract tumors, lymphoma, and soft tissue sarcoma.
Name order: in Chinese the family name comes first (Wang Shulian). Papers usually list the name as Shulian Wang or Wang S.
Selected publications
211 papers on PubMed matched by name and affiliation; 40 as first or senior author since 2016. Most recent first- or senior-author papers:
- Lancet Oncol, 2026 (senior author): Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer (CHN HYPOPMRT): 10-year outcomes from a randomised, non-inferiority, open-label, phase 3 trial. PubMed 42805199
- Discov Oncol, 2026 (senior author): A nomogram to predict pathological axillary lymph node status in neoadjuvant chemotherapy-treated patients with breast cancer. PubMed 42467123
- Adv Radiat Oncol, 2026 (senior author): Optimizing Cardiac Dose Prediction in Left-Sided Breast Cancer Radiation Therapy: Clinical Strategies for Identifying Beneficiaries of the Deep Inspiration Breath-Hold Technique. PubMed 42199527
- Int J Cancer, 2026 (senior author): Dosimetric and clinical predictors for radiation esophagitis in patients with breast cancer undergoing conventional fractionated regional nodal irradiation: A prospective study. PubMed 40966125
- Radiother Oncol, 2025 (senior author): Prospective cohort study to validate esophageal dose constraints and predictive models for esophagitis in patients with breast cancer undergoing hypofractionated regional nodal radiotherapy. PubMed 40921329
- Ther Adv Med Oncol, 2025 (senior author): A recurrence risk score model evaluating effects of postmastectomy radiotherapy in breast cancer patients with pathologically negative lymph nodes after neoadjuvant chemotherapy: a multicenter, retrospective study. PubMed 41024932
- Ther Adv Med Oncol, 2025 (senior author): Depression and anxiety in patients with breast cancer receiving radiotherapy: a longitudinal study. PubMed 40656597
- Clin Transl Radiat Oncol, 2025 (senior author): Comparison of simultaneous integrated tumor bed boost and sequential boost during hypofractionated whole-breast irradiation after breast-conserving surgery. PubMed 40469948
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion